Skip to main content
Top
Published in: Medical Oncology 5/2018

Open Access 01-05-2018 | Original Paper

Role of matrix metalloproteinases in tumour invasion: immunohistochemistry of peritoneum from peritoneal carcinomatosis

Authors: Peter Falk, Andreas Jonsson, Torbjörn Swartling, Dan Asplund, Marie-Lois Ivarsson

Published in: Medical Oncology | Issue 5/2018

Login to get access

Abstract

Colorectal cancer is one of the most common forms of cancer. Spread of tumour to the peritoneal cavity may lead to seeding of cancer cells that adhere to and invade the peritoneal membrane causing peritoneal carcinomatosis. Matrix metalloproteinases (MMPs) play an essential role in cancer cell invasion and dissemination. The aim of this study was to evaluate the morphology and presence of matrix metalloproteinases in peritoneal carcinomatosis. Biopsy samples of the parietal peritoneum were taken from patients undergoing cytoreductive surgery for peritoneal carcinomatosis. The samples were fixed in formalin, dehydrated and embedded in paraffin prior to cutting into 4-µm slices. Staining with haematoxylin/eosin was used for morphology studies, and MMP-1, MMP-2 and TIMP-1 levels were evaluated using immunohistochemistry and light microscopy. The microscopically tumour-free areas of the peritoneal membrane were thin compared to the peripheral invasion zone and the areas invaded by tumour. Peritoneum invaded by tumour was richly vascularised and contained inflammatory cells. MMP-1 was expressed in tumour-free peritoneum and in the invasion zone between tumour and peritoneal tissue, but not in tumour-invaded areas. MMP-2 and TIMP-1 were mostly expressed in the proximity of blood vessels and inflammatory cells in tumour-invaded areas, but was not seen in tumour-free areas. MMPs play an important role in the process of cancer cell invasion of the peritoneum in peritoneal carcinomatosis. The peripheral zone of the tumour appears to be of importance for tumour invasion.
Literature
1.
go back to reference diZerega GS. Peritoneum, peritoneal healing, and adhesion formation. Peritoneal surgery. New York: Springer; 2000. diZerega GS. Peritoneum, peritoneal healing, and adhesion formation. Peritoneal surgery. New York: Springer; 2000.
2.
go back to reference van der Wal JB, Jeekel J. Biology of the peritoneum in normal homeostasis and after surgical trauma. Colorectal Dis. 2007;9(Suppl 2):9–13.PubMed van der Wal JB, Jeekel J. Biology of the peritoneum in normal homeostasis and after surgical trauma. Colorectal Dis. 2007;9(Suppl 2):9–13.PubMed
3.
go back to reference Lejeune FJ. Is Surgical Trauma Prometastatic? Anticancer Res. 2012;32(3):947–51.PubMed Lejeune FJ. Is Surgical Trauma Prometastatic? Anticancer Res. 2012;32(3):947–51.PubMed
4.
go back to reference Langenskiöld M. Tissue remodelling proteases as prognostic factors in colon and rectal cancer. Göteborg: Göteborgs universitet; 2009. Langenskiöld M. Tissue remodelling proteases as prognostic factors in colon and rectal cancer. Göteborg: Göteborgs universitet; 2009.
5.
go back to reference Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1(8496):1479–82.CrossRefPubMed Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1(8496):1479–82.CrossRefPubMed
9.
go back to reference Zeng ZS, Cohen AM, Guillem JG. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis. 1999;20(5):749–55.CrossRefPubMed Zeng ZS, Cohen AM, Guillem JG. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis. 1999;20(5):749–55.CrossRefPubMed
12.
go back to reference Sunami E, Tsuno N, Osada T, Saito S, Kitayama J, Tomozawa S, et al. MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist. 2000;5(2):108–14.CrossRefPubMed Sunami E, Tsuno N, Osada T, Saito S, Kitayama J, Tomozawa S, et al. MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist. 2000;5(2):108–14.CrossRefPubMed
13.
go back to reference Langenskiold M, Holmdahl L, Falk P, Ivarsson ML. Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer. Int J Colorectal Dis. 2005;20(3):245–52.CrossRefPubMed Langenskiold M, Holmdahl L, Falk P, Ivarsson ML. Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer. Int J Colorectal Dis. 2005;20(3):245–52.CrossRefPubMed
14.
go back to reference Solberg A, Holmdahl L, Falk P, Palmgren I, Ivarsson ML. A local imbalance between MMP and TIMP may have an implication on the severity and course of appendicitis. Int J Colorectal Dis. 2008;23(6):611–8.CrossRefPubMed Solberg A, Holmdahl L, Falk P, Palmgren I, Ivarsson ML. A local imbalance between MMP and TIMP may have an implication on the severity and course of appendicitis. Int J Colorectal Dis. 2008;23(6):611–8.CrossRefPubMed
15.
go back to reference Angenete E, Oresland T, Falk P, Breimer M, Hultborn R, Ivarsson ML. Preoperative radiotherapy and extracellular matrix remodeling in rectal mucosa and tumour matrix metalloproteinases and plasminogen components. Acta Oncol. 2009;48(8):1144–51.CrossRefPubMed Angenete E, Oresland T, Falk P, Breimer M, Hultborn R, Ivarsson ML. Preoperative radiotherapy and extracellular matrix remodeling in rectal mucosa and tumour matrix metalloproteinases and plasminogen components. Acta Oncol. 2009;48(8):1144–51.CrossRefPubMed
17.
go back to reference Jayne DG. The molecular biology of peritoneal carcinomatosis from gastrointestinal cancer. Ann Acad Med Singap. 2003;32(2):219–25.PubMed Jayne DG. The molecular biology of peritoneal carcinomatosis from gastrointestinal cancer. Ann Acad Med Singap. 2003;32(2):219–25.PubMed
19.
go back to reference Mutsaers SE. Mesothelial cells: their structure, function and role in serosal repair. Respirology. 2002;7(3):171–91.CrossRefPubMed Mutsaers SE. Mesothelial cells: their structure, function and role in serosal repair. Respirology. 2002;7(3):171–91.CrossRefPubMed
20.
go back to reference Ivarsson ML, Bergstrom M, Eriksson E, Risberg B, Holmdahl L. Tissue markers as predictors of postoperative adhesions. Br J Surg. 1998;85(11):1549–54.CrossRefPubMed Ivarsson ML, Bergstrom M, Eriksson E, Risberg B, Holmdahl L. Tissue markers as predictors of postoperative adhesions. Br J Surg. 1998;85(11):1549–54.CrossRefPubMed
21.
go back to reference Sikkink CJ, Reijnen MM, Falk P, van Goor H, Holmdahl L. Influence of monocyte-like cells on the fibrinolytic activity of peritoneal mesothelial cells and the effect of sodium hyaluronate. Fertil Steril. 2005;84(Suppl 2):1072–7.CrossRefPubMed Sikkink CJ, Reijnen MM, Falk P, van Goor H, Holmdahl L. Influence of monocyte-like cells on the fibrinolytic activity of peritoneal mesothelial cells and the effect of sodium hyaluronate. Fertil Steril. 2005;84(Suppl 2):1072–7.CrossRefPubMed
22.
go back to reference Chegini N, Kotseos K, Zhao Y, Ma C, McLean F, Diamond MP, et al. Expression of matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP in serosal tissue of intraperitoneal organs and adhesions. Fertil Steril. 2001;76(6):1212–9.CrossRefPubMed Chegini N, Kotseos K, Zhao Y, Ma C, McLean F, Diamond MP, et al. Expression of matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP in serosal tissue of intraperitoneal organs and adhesions. Fertil Steril. 2001;76(6):1212–9.CrossRefPubMed
23.
go back to reference Raftery AT. Regeneration of parietal and visceral peritoneum. A light microscopical study. Br J Surg. 1973;60:293–9.CrossRefPubMed Raftery AT. Regeneration of parietal and visceral peritoneum. A light microscopical study. Br J Surg. 1973;60:293–9.CrossRefPubMed
24.
go back to reference Raftery AT. Regeneration of parietal and visceral peritoneum: an electron microscopical study. J Anat. 1973;115:375–92.PubMedPubMedCentral Raftery AT. Regeneration of parietal and visceral peritoneum: an electron microscopical study. J Anat. 1973;115:375–92.PubMedPubMedCentral
26.
go back to reference Takeuchi T, Iwasaki S, Miyazaki J, Nozaki Y, Takahashi M, Ono M, et al. Matrix metalloproteinase-1 expression in splenic angiosarcoma metastasizing to the serous membrane. Int J Clin Exp Pathol. 2010;3(6):634–9.PubMedPubMedCentral Takeuchi T, Iwasaki S, Miyazaki J, Nozaki Y, Takahashi M, Ono M, et al. Matrix metalloproteinase-1 expression in splenic angiosarcoma metastasizing to the serous membrane. Int J Clin Exp Pathol. 2010;3(6):634–9.PubMedPubMedCentral
Metadata
Title
Role of matrix metalloproteinases in tumour invasion: immunohistochemistry of peritoneum from peritoneal carcinomatosis
Authors
Peter Falk
Andreas Jonsson
Torbjörn Swartling
Dan Asplund
Marie-Lois Ivarsson
Publication date
01-05-2018
Publisher
Springer US
Published in
Medical Oncology / Issue 5/2018
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-018-1122-7

Other articles of this Issue 5/2018

Medical Oncology 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.